148 related articles for article (PubMed ID: 6410625)
1. [Combined Staphylococcus-Proteus-Pseudomonas vaccine. II. The toxicity of the vaccine in "chronic" experiments and its ability to protect animals against Proteus and Staphylococcus infections].
Kreĭnin LS; Egorova NB; Stanislavskiĭ ES; Kaverina KG; Levina LA
Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):87-92. PubMed ID: 6410625
[TBL] [Abstract][Full Text] [Related]
2. [Preventive properties of the blood sera from persons vaccinated with a Proteus vaccine made from soluble antigen complexes].
Levina LA; Kreĭnin LS; Kaverina KG; Zdanovskaia LK; Iurova VA
Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):84-8. PubMed ID: 3087123
[TBL] [Abstract][Full Text] [Related]
3. [Immunological activity of a Proteus vaccine administered to volunteers simultaneously with a pyoimmunogen and adsorbed staphylococcal anatoxin].
Levina LA; Iurova VA; Kreĭnin LS; Kaverina KG; Dubova VG
Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):57-61. PubMed ID: 3128030
[TBL] [Abstract][Full Text] [Related]
4. [A complex vaccine in the prevention of staphylococcal, Pseudomonas aeruginosa and Proteus infections in esophageal cancer patients].
Kochetkova VA; Moskovtseva RL; Mamontov AS
Vopr Onkol; 1987; 33(2):58-63. PubMed ID: 3825005
[TBL] [Abstract][Full Text] [Related]
5. [The antigenic activity of vaccines made from opportunistic microorganisms in an experiment to immunize animals by oral and combined methods].
Efremova VN; Poliachenko VM; Kaverina KG
Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):40-3. PubMed ID: 1441812
[TBL] [Abstract][Full Text] [Related]
6. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI
Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
[TBL] [Abstract][Full Text] [Related]
7. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally].
Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG
Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073
[TBL] [Abstract][Full Text] [Related]
8. [Protective properties of Proteus ribosomal vaccine].
Ovetchin PV; Tsyganenko AIa
Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):19-23. PubMed ID: 6367317
[TBL] [Abstract][Full Text] [Related]
9. [Combined Staphylococcus-Proteus-Pseudomonas vaccine. I. Effectiveness of the vaccine in experimental Pseudomonas aeruginosa infections].
Stanislavskiĭ ES; Kreĭnin LS; Egorova NB; Kaverina KG; Efremova VN
Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):57-61. PubMed ID: 7331610
[No Abstract] [Full Text] [Related]
10. [The immunogenicity of mono- and associated vaccines made from strains of opportunistic bacteria].
Soboleva SV
Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):31-4. PubMed ID: 1801485
[TBL] [Abstract][Full Text] [Related]
11. Early protection by vaccines in burns.
Jones RJ
Br J Exp Pathol; 1971 Feb; 52(1):100-9. PubMed ID: 4993954
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
13. Vaccines against Pseudomonas aeruginosa infection: 1. Experimental studies.
Stanislavsky ES; Joo I; Mashilova GM; Boolk VF; Boltutsy LG; Zakgeim DA; Severtśova MK; Yedvabnaya LS; Gladus MA; Fatkhinurova TI
Vaccine; 1985 Jun; 3(2):128-36. PubMed ID: 3929491
[TBL] [Abstract][Full Text] [Related]
14. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously].
Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG
Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974
[TBL] [Abstract][Full Text] [Related]
15. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice].
Bulava GV; Ermolin GA
Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845
[TBL] [Abstract][Full Text] [Related]
16. [Protective properties of antigenic complexes of Proteus].
Kreĭnin LS; Kaverina KG; Aksenova EV; Buatkova LIu
Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):60-4. PubMed ID: 7015763
[TBL] [Abstract][Full Text] [Related]
17. [The results of experimental and clinical studies of a multicomponent vaccine made of the antigens from opportunistic microorganisms].
Egorova NB; Efremova VN; Kurbatova EA; Kuz'mina LA
Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):96-101. PubMed ID: 9460881
[No Abstract] [Full Text] [Related]
18. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
Zaĭtsev EV; Levina LA
Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
[TBL] [Abstract][Full Text] [Related]
19. [Problems of the immunoprophylaxis of experimental Pseudomonas pyocyanea wound sepsis].
Kolker II; Stanislavskiĭ ES; Grishina IA
Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):67-72. PubMed ID: 110018
[TBL] [Abstract][Full Text] [Related]
20. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine.
Sachs A
Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
